NCT00755118 Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc Status TERMINATED Phase PHASE2
NCT00673179 Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy Status TERMINATED Phase NA
NCT00663481 A Clinical Trial of CoFactor Formulations and Leucovorin Administered Intravenously in Healthy, Adult Subjects. Status COMPLETED Phase PHASE1
NCT00642746 Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC) Status TERMINATED Phase PHASE2
NCT00642577 A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer. Status COMPLETED Phase PHASE3
NCT00634322 High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma Status TERMINATED Phase PHASE2
NCT00632827 Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak) Status TERMINATED Phase PHASE2
NCT00577109 A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer. Status WITHDRAWN Phase PHASE2
NCT00559455 Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00539617 Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery Status TERMINATED Phase PHASE2
NCT00537823 Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement Status TERMINATED Phase PHASE2
NCT00515216 Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors Status COMPLETED Phase PHASE2
NCT00508872 Folfox-B Study for Patients With Colorectal Liver Metastases Status TERMINATED Phase PHASE2
NCT00507585 Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin Status COMPLETED Phase PHASE1
NCT00507091 Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination Status COMPLETED Phase PHASE1
NCT00501410 FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00469443 Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC Status COMPLETED Phase PHASE3
NCT00450801 R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00449163 Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer Status TERMINATED Phase PHASE2